H5Health Limited 10706231 false 2024-05-01 2025-04-30 2025-04-30 The principal activity of the company is medical services. Digita Accounts Production Advanced 6.30.9574.0 true 10706231 2024-05-01 2025-04-30 10706231 2025-04-30 10706231 core:RetainedEarningsAccumulatedLosses 2025-04-30 10706231 core:ShareCapital 2025-04-30 10706231 core:CurrentFinancialInstruments core:WithinOneYear 2025-04-30 10706231 bus:SmallEntities 2024-05-01 2025-04-30 10706231 bus:AuditExemptWithAccountantsReport 2024-05-01 2025-04-30 10706231 bus:FullAccounts 2024-05-01 2025-04-30 10706231 bus:SmallCompaniesRegimeForAccounts 2024-05-01 2025-04-30 10706231 bus:RegisteredOffice 2024-05-01 2025-04-30 10706231 bus:Director1 2024-05-01 2025-04-30 10706231 bus:Director2 2024-05-01 2025-04-30 10706231 bus:PrivateLimitedCompanyLtd 2024-05-01 2025-04-30 10706231 countries:EnglandWales 2024-05-01 2025-04-30 10706231 2023-05-01 2024-04-30 10706231 2024-04-30 10706231 core:RetainedEarningsAccumulatedLosses 2024-04-30 10706231 core:ShareCapital 2024-04-30 10706231 core:CurrentFinancialInstruments core:WithinOneYear 2024-04-30 iso4217:GBP xbrli:pure

Registration number: 10706231

H5Health Limited
Annual Report and Unaudited Filleted Abridged Financial Statements
for the Year Ended 30 April 2025

H5Health Limited

Contents

Abridged Balance Sheet | 1
Notes to the Unaudited Abridged Financial Statements | 2

H5Health Limited

(Registration number: 10706231)
Abridged Balance Sheet as at 30 April 2025

| 2025 £ | 2024 £
Current assets |  |
Cash at bank and in hand | 13,227 | 22,163
Creditors: Amounts falling due within one year | (9,238) | (9,534)
Net assets | 3,989 | 12,629
Capital and reserves |  |
Called up share capital | 1 | 1
Profit and loss account | 3,988 | 12,628
Total equity | 3,989 | 12,629

For the financial year ending 30 April 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

| The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
| The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

All of the company’s members have consented to the preparation of an Abridged Profit and Loss Account and an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

Approved and authorised by the Board on 31 October 2025 and signed on its behalf by:

Dr C Murdoch

Director

Mrs R Murdoch

Director

H5Health Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 30 April 2025

1 | General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Ling Heather
The Street
Farmborough
Bath
Somerset
BA2 0AR

These financial statements were authorised for issue by the Board on 31 October 2025.

2 | Accounting policies

Statement of compliance

These abridged financial statements were prepared in accordance with Financial Reporting Standard 102 Section 1A 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.
The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

3 | Staff numbers

The average number of persons employed by the company (including directors) during the year, was 2 (2024 - 2).